Skip to Sidebar Menu Skip to Content

Industry & Partnership

Perry Hackett’s Sleeping Beauty Transposon System is a gene transfer platform that can be used to reprogram the human immune system to find and attack cancer cells. Last year, two biotech companies licensed a cancer treatment involving Sleeping Beauty to pharmaceutical company Merck for nearly $1 billion.

Learn about other entrepreneurial innovators recently honored for their achievements.


Partnering U research, the state, and industries to enhance quality of life and promote economic vitality.


NIH-funded initiative to nurture innovators to develop high-priority technologies.


NSF-funded initiative to increase research-based technology commercialization capabilities and activities.